Document is current
Any future updates will be listed below
-
Authors
Kellner, Shai
Berlin, Shai https://orcid.org/0000-0002-5153-4876
-
Funding
Funding for this research was provided by:
Israel Science Foundation (1096/17)
Teva Pharmaceutical Industries (PR783187)
2BCured charitable fund (Berlin-Donation)
- License Information
-
More Information
Article History
Received: 9 October 2023
Revised: 16 April 2024
Accepted: 18 April 2024
First Online: 25 May 2024
Declarations
:
: The authors declare that they have no competing interests.
: The Technion Institutional Animal Care and Use Committee approved all experiments with <i>Xenopus laevis</i> oocytes (permit SB, no. IL-162–10-25), rat hippocampal neurons (permit SB, no. IL-143–12-20) and for the design of a transgenic mouse model bearing the <i>GRIN2B</i>-G689C patient-derived variant (permit SB, no. IL-125–11-20).
: All authors approve the manuscript and its publication.
